Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil + remimazolam dose-finding and pharmacokinetic study for hysteroscopic day surgery
ChiCTR2500097312Phase 4Not yet recruiting
- Sponsor
- Qingdao Women and Children’s Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfentanil and remimazolam, sponsored by Qingdao Women and Children’s Hospital. Primary endpoint: Intraoperative body movements. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
alfentanilremimazolam
Beyond the preview
Go deeper on ChiCTR2500097312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097312.